85
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Activated protein C resistance in cord blood from healthy and complicated newborns

, MD, , , &
Pages 797-801 | Received 22 Dec 2006, Accepted 04 Jun 2007, Published online: 07 Jul 2009

References

  • Nowak-Göttl U, Kosch A, Schlegel N. Thromboembolism in newborns infants and children. Thromb Haemost 2001; 86: 464–474
  • Nowak-Göttl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M. Thromboembolism in children. Curr Opin Hematol 2002; 9: 448–453
  • Nowak-Göttl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: 163–167
  • Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95–104
  • Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900–906
  • Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939–943
  • Nowak-Gottl U, Koch H G, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszcuk-Raschke K, Kehl H G, Jurgens H, Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996; 92: 992–998
  • Dahlback B. Activated protein C resistance and thrombosis. Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Haemost 1999; 25: 273–289
  • Rodeghiero F, Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999; 130: 643–650
  • Hellgren M, Svensson P J, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995; 173: 210–213
  • Paternoster D M, Stella A, Simioni P, Girolami A, Snijders D. Activated protein C resistance in normal and pre-eclamptic pregnancies. Gynecol Obstet Invest 2002; 54: 145–149
  • Sifontes M T, Nuss R, Hunger S P, Jacobson L J, Waters J, Manco-Johnson M J. Correlation between the functional assay for activated protein C resistance and factor V Leiden in the neonate. Pediatr Res 1997; 42: 776–778
  • Michiels J J, Hamulyak K. Laboratory diagnosis of hereditary thrombophilia. Semin Thromb Haemost 1998; 24: 309–320
  • Brandt G, Gruppo R, Glueck C J, Stroop D, Becker A, Pillow A, Wang P. Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in children. Thromb Haemost 1998; 79: 567–570
  • Cvirn G, Gallistl S, Koestenberger M, Baier K, Fritsch P, Greilberger J, Jurgens G, Muntean W. The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): Comparison between cord and adult plasma. Thromb Haemost 2004; 91: 912–918
  • Uttenreuther-Fischer M M, Ziemer S, Gaedicke G. Resistance to activated protein C (APCR): Reference values of APC-ratios for children. Thromb Haemost 1996; 76: 813–814
  • Oger E, Leroyer C, Mercier B, Van Dreden P, Bressollette L, De Saint-Martin L, Le Moigne E, Blouch M T, Thuillier N, Amiral J, et al. Assessment of activated protein C resistance using a new and rapid venom-based test: STA Statclot APC-R. Blood Coagul Fibrinolysis 1998; 9: 355–359
  • Lao T T, Yin J A, Yuen P M. Coagulation and anticoagulation systems in newborns—correlation with their mothers at delivery. Lower levels of anticoagulants and fibrinolytic activity in newborn. Gynecol Obstet Invest 1990; 29: 181–184
  • Franzoi M, Simioni P, Luni S, Zerbinati P, Girolami A, Zanardo V. Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. Thromb Research 2002; 105: 15–18
  • Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Di Minno G. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77: 822–824
  • Hathaway W E, Mahasandana C, Makowski E L. Cord blood coagulation studies in infants of high risk pregnant women. Am J Obstet Gynecol 1975; 121: 51–57
  • Tanjung M T, Siddik H D, Hariman H, Koh S C. Coagulation and fibrinolysis in preeclampsia and neonate. Clin Appl Thromb Haemost 2005; 11: 467–473
  • Zanardo V, Savio V, Sabrina G, Franzoi M, Zerbinati P, Fadin M, Tognin G, Tormene D, Pagnan A, Simioni P. The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns. Blood Coagul Fibrinolysis 2005; 16: 177–181
  • de Ronde H, Bertina R M. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880–886

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.